Enanta Pharmaceuticals, Inc.: Enanta Pharmaceuticals to Pres

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections, today announced that data for EDP-235, its lead 3CL

Related Keywords

France , Dennis Riedl , Presenterindy Zhang , Jennifer Viera , Michael Rhodin , Presentertessa Cressey , International Conference On Antiviral Research , Enanta Pharmaceuticals Inc , Nasdaq , Enanta Pharmaceuticals , International Conference , Antiviral Research , Centre De Congres Lyon , Lyon Convention Center , Central European Time , Suppresses Viral Replication , Oral Antiviral , Demonstrates Excellent Penetration , Viral Rebound , Cindy Zhang , Once Daily , Guy De La Rosa , Throughput Screen , Identify Non Nucleoside Small Molecule Inhibitors , Tessa Cressey , Menanta , Pharmaceuticals , Present , Data , Protease , Inhibitor , Development , Mural , Dance , Daily , Treatment , Covid , 6th , Nternational , Conference , Antiviral , Research ,